No Data
PRIVACY ALERT: Summit Pathology Under Investigation for Data Breach of Over 1.8 Million Patient Records
BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential
AppLovin's Stock Easily Seals Its Best Week Ever. It's Now up 600% This Year.
For the 4th Time, Summit Medical Staffing Makes the Inc. 5000, at No. 126 in 2024
Why Summit Therapeutics Stock Was a Winner Today
Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo